HPSE and breast cancer: MiR-1258 changes are directly linked to the expression of heparanase, which is an established prometastatic enzyme found in BM in breast cancer cells that degrades chains of heparan sulfate to alter the cytoskeleton and makes it easier for cells to cross the BBB40,41.